Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroendocrine Tumors | Preclinical | Canada | 10 May 2025 |





